First Financial Corp Zoetis Inc. Transaction History

First Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$165.67 - $199.94 $31,808 - $38,388	-192 Reduced 88.48%	25 $4,000
Q4 2023 Jan 16, 2024	BUY	$151.44 - $200.09 $11,963 - $15,807	79 Added 57.25%	217 $42,000
Q2 2023 Jul 14, 2023	BUY	$160.94 - $186.23 $1,287 - $1,489	8 Added 6.15%	138 $23,000
Q4 2022 Jan 17, 2023	BUY	$131.14 - $157.47 $2,229 - $2,676	17 Added 15.04%	130 $0
Q3 2019 Oct 15, 2019	BUY	$112.57 - $128.43 $12,720 - $14,512	113 New	113 $14,000

1,897

423M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $88.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

Stay updated on First Financial Corp with notifications on news.